1
|
Kubo S, Mimaki Y, Terao M, Sashida Y,
Nikaido T and Ohmoto T: Acylated cholestane glycosides from the
bulbs of Ornithogalum saudersiae. Phytochemistry.
31:3969–3973. 1992. View Article : Google Scholar
|
2
|
Mimaki Y, Kuroda M, Kameyama A, Sashida Y,
Hirano T and Oka K: Cholestane glycosides with potent cytostatic
activities on various tumor cells from Ornithogalum
saundersiae bulbs. Bioorg Med Chem Lett. 7:633–636. 1997.
View Article : Google Scholar
|
3
|
Zhou Y, Garcia-Prieto C, Carney DA, et al:
OSW-1: a natural compound with potent anticancer activity and a
novel mechanism of action. J Natl Cancer Inst. 97:1781–1785. 2005.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Deng S, Yu B, Lou Y and Hui Y: First total
synthesis of an exceptionally potent antitumor saponin, OSW-1. J
Org Chem. 64:202–208. 1999. View Article : Google Scholar : PubMed/NCBI
|
5
|
Morris KV, Chan SW, Jacobsen SE and Looney
DJ: Small interfering RNA-induced transcriptional gene silencing in
human cells. Science. 305:1289–1292. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Jeyaseelan K, Herath WB and Armugam A:
MicroRNAs as therapeutic targets in human diseases. Expert Opin
Ther Targets. 11:1119–1129. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Scherr M and Eder M: Gene silencing by
small regulatory RNAs in mammalian cells. Cell Cycle. 6:444–449.
2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Cleveland WS: LOWESS: A program for
smoothing scatterplots by robust locally weighted regression. Am
Stat. 35:541981. View
Article : Google Scholar
|
9
|
Yang YH, Dudoit S, Luu P, Lin DM, Peng V,
Ngai J and Speed TP: Normalization for cDNA microarray data: a
robust composite method addressing single and multiple slide
systematic variation. Nucleic Acids Res. 30:e152002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Saeed AI, Bhagabati NK, Braisted JC, Liang
W, Sharov V, Howe EA, et al: TM4 microarray software suite. Methods
in Enzymology. 411:134–193. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Shevde LA, Metge BJ, Mitra A, Xi Y, Ju J,
King JA and Samant RS: Spheroid-forming subpopulation of breast
cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p
regulated de novo expression of osteopontin. J Cell Mol Med.
14:1693–1706. 2010. View Article : Google Scholar
|
12
|
Liang L, Wong CM, Ying Q, et al:
MicroRNA-125b suppressesed human liver cancer cell proliferation
and metastasis by directly targeting oncogene LIN28B2. Hepatology.
52:1731–1740. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Le MT, Teh C, Shyh-Chang N, et al:
MicroRNA-125b is a novel negative regulator of p53. Genes Dev.
23:862–876. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Jin J, Jin X, Qian C, Ruan Y and Jiang H:
Signaling network of OSW 1 induced apoptosis and necroptosis in
hepatocellular carcinoma. Mol Med Rep. 7:1646–1650. 2013.PubMed/NCBI
|
15
|
Nikiforova MN, Tseng GC, Steward D, Diorio
D and Nikiforov YE: MicroRNA expression profiling of thyroid
tumors: biological significance and diagnostic utility. J Clin
Endocrinol Metab. 93:1600–1608. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Favaro E, Ramachandran A, McCormick R, et
al: MicroRNA-210 regulates mitochondrial free radical response to
hypoxia and krebs cycle in cancer cells by targeting iron sulfur
cluster protein ISCU. PLoS One. 5:e103452010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Mizutani H, Tada-Oikawa S, Hiraku Y,
Kojima M and Kawanishi S: Mechanism of apoptosis induced by
doxorubicin through the generation of hydrogen peroxide. Life Sci.
76:1439–1453. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Groninger E, Meeuwsen-De Boer GJ, De Graaf
SS, Kamps WA and De Bont ES: Vincristine induced apoptosis in acute
lymphoblastic leukaemia cells: a mitochondrial controlled pathway
regulated by reactive oxygen species? Int J Oncol. 21:1339–1345.
2002.
|
19
|
Veronese A, Lupini L, Consiglio J, et al:
Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res.
70:3140–3149. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wang S, Aurora AB, Johnson BA, et al: The
endothelial-specific microRNA miR-126 governs vascular integrity
and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhang Y, Wang Y, Wang X, et al: Insulin
promotes vascular smooth muscle cell proliferation via
microRNA-208-mediated downregulation of p21. J Hypertens.
29:1560–1568. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wu L, Cai C, Wang X, Liu M, Li X and Tang
H: MicroRNA-142-3p, a new regulator of RAC1, suppresses the
migration and invasion of hepatocellular carcinoma cells. FEBS
Lett. 585:1322–1330. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Sharma S, Liu J, Wei J, Yuan H, Zhang T
and Bishopric NH: Repression of miR-142 by p300 and MAPK is
required for survival signalling via gp130 during adaptive
hypertrophy. EMBO Mol Med. 4:617–632. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hurteau GJ, Carlson JA, Spivack SD and
Brock GJ: Overexpression of the microRNA hsa-miR-200c leads to
reduced expression of transcription factor 8 and increased
expression of E-cadherin. Cancer Res. 67:7972–7976. 2007.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Nakada C, Matsuura K, Tsukamoto Y, et al:
Genome-wide microRNA expression profiling in renal cell carcinoma:
significant down-regulation of miR-141 and miR-200c. J Pathol.
216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|